Drug interactions
Linzagolix + Sorafenib
Severity: Major
Linzagolix and Sorafenib: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Linzagolix may increase sorafenib concentrations through CYP2C8 inhibition, raising the risk of dose-related toxicity such as hand-foot reactions and hypertension.
What this interaction means in plain words
Linzagolix and Sorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Linzagolix belongs to Endocrine; Sorafenib belongs to Oncology.
Why it happens
Inhibition of CYP2C8 by linzagolix reduces sorafenib clearance.
What to do
Avoid combination where possible; otherwise monitor for sorafenib adverse effects and reduce dose as needed.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Linzagolix and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Linzagolix
- Linzagolix + Paclitaxel Major
- Linzagolix + Repaglinide Major
Other interactions of Sorafenib
Frequently asked questions
Can I take Linzagolix with Sorafenib?
MediHelp rates the interaction as major. Linzagolix and Sorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Linzagolix may increase sorafenib concentrations through CYP2C8 inhibition, raising the risk of dose-related toxicity such as hand-foot reactions and hypertension.
How serious is the interaction between Linzagolix and Sorafenib?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combination where possible; otherwise monitor for sorafenib adverse effects and reduce dose as needed.
What other medicines interact with Linzagolix?
MediHelp also lists interactions of Linzagolix with, for example, Paclitaxel, Repaglinide. The full list is on the Linzagolix page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
